Aroa Biosurgery Statistics

Total Valuation

Aroa Biosurgery has a market cap or net worth of AUD 241.43 million. The enterprise value is 227.65 million.

Market Cap	241.43M
Enterprise Value	227.65M

Important Dates

The next estimated earnings date is Thursday, January 23, 2025.

Earnings Date	Jan 23, 2025
Ex-Dividend Date	n/a

Share Statistics

Aroa Biosurgery has 344.90 million shares outstanding. The number of shares has increased by 0.35% in one year.

Current Share Class	n/a
Shares Outstanding	344.90M
Shares Change (YoY)	+0.35%
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	24.77%
Owned by Institutions (%)	28.20%
Float	259.47M

Valuation Ratios

PE Ratio	n/a
Forward PE	68.88
PS Ratio	3.44
PB Ratio	2.86
P/TBV Ratio	3.40
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-32.56
EV / Sales	3.25
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-31.31

Financial Position

The company has a current ratio of 8.53, with a Debt / Equity ratio of 0.07.

Current Ratio	8.53
Quick Ratio	6.80
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	-0.87
Interest Coverage	-19.49

Financial Efficiency

Return on equity (ROE) is -8.05% and return on invested capital (ROIC) is -6.10%.

Return on Equity (ROE)	-8.05%
Return on Assets (ROA)	-5.67%
Return on Capital (ROIC)	-6.10%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.70
Inventory Turnover	1.26

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +2.86% in the last 52 weeks. The beta is 0.69, so Aroa Biosurgery's price volatility has been lower than the market average.

Beta (5Y)	0.69
52-Week Price Change	+2.86%
50-Day Moving Average	0.61
200-Day Moving Average	0.57
Relative Strength Index (RSI)	70.44
Average Volume (20 Days)	570,026

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Aroa Biosurgery had revenue of AUD 70.08 million and -6.99 million in losses. Loss per share was -0.02.

Revenue	70.08M
Gross Profit	60.72M
Operating Income	-9.09M
Pretax Income	-6.58M
Net Income	-6.99M
EBITDA	-5.98M
EBIT	-9.09M
Loss Per Share	-0.02

Full Income Statement

Balance Sheet

The company has 20.10 million in cash and 6.32 million in debt, giving a net cash position of 13.78 million or 0.04 per share.

Cash & Cash Equivalents	20.10M
Total Debt	6.32M
Net Cash	13.78M
Net Cash Per Share	0.04
Equity (Book Value)	84.49M
Book Value Per Share	0.24
Working Capital	51.84M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -4.54 million and capital expenditures -2.73 million, giving a free cash flow of -7.27 million.

Operating Cash Flow	-4.54M
Capital Expenditures	-2.73M
Free Cash Flow	-7.27M
FCF Per Share	-0.02

Full Cash Flow Statement

Margins

Gross margin is 86.63%, with operating and profit margins of -12.97% and -9.97%.

Gross Margin	86.63%
Operating Margin	-12.97%
Pretax Margin	-9.39%
Profit Margin	-9.97%
EBITDA Margin	-8.53%
EBIT Margin	-12.97%
FCF Margin	-10.37%

Dividends & Yields

Aroa Biosurgery does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.35%
Shareholder Yield	-0.35%
Earnings Yield	n/a
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Aroa Biosurgery has an Altman Z-Score of 10.32.

Altman Z-Score	10.32
Piotroski F-Score	n/a